US Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth

US Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth

Summary

GlobalData’s “US Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth” report is an essential source of data and analysis on the US coronary stents market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories – bare metal stents and drug eluting stents. The report identifies the key trends shaping and driving the dynamism in the US coronary stents market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the US coronary stents market.

Scope

- The report provides market size data and information on two US coronary stents market categories – bare metal stents and drug eluting stents.
- Annualized market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
- Analysis and review of the key events and milestones that will impact the future of the US coronary stents market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the US coronary stents market in the long run.
- In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the US coronary stents Market.
- Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the US coronary stents market in future.
- Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- What’s the next being thing in the US coronary stents technology landscape? – Identify, understand and capitalize.

1 Table Of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Executive Summary 7
3 Coronary Stents Market Overview 8
3.1 Introduction and Definition 8
3.1.1 Coronary Stents 8
3.1.1.1 Bare Metal Stents 8
3.1.1.2 Drug Eluting Coronary Stents 8
3.2 Market Overview 9
3.2.1 Risk Factors for Coronary Disease 12
3.3 Cross Category Analysis 13
3.3.1 US Interventional Cardiology Market Cross Category Analysis (2001-2015) 13
3.4 Competitive Landscape 14
3.5 The US Coronary Stents Market: Trend Analysis 16
3.5.1 Market Snapshot 16
3.5.2 Emergence of DES - Overview 16
3.5.2.1 Drug Eluting Stent (DES) Market: Drivers 17
3.5.2.2 Drug Eluting Stents (DES) Market: Restraints 18
3.5.3 Stent Coatings 18
3.5.4 Stent Implantation Procedure – Overview 19
3.5.5 Key End Users 20
3.5.6 The US Coronary Stent Market: Drivers 20
3.5.6.1 Increased obesity rates in some population groups enhances the demand for Percutaneous Coronary Intervention (PCI) 20
3.5.6.2 Developments in Imaging Enhanced Accuracy of Implantation and Surgical Procedures 21
3.5.6.3 The Next Generation of Hybrid Devices Could Increase Treatment Outcome and Device Applicability 21
3.5.7 The US Coronary Stents Market: Restraints 21
3.5.7.1 Negative promotion activities related to stents market have affected the usage of DES 21
3.5.7.2 High price of treating cardiovascular diseases results in more economics based decision making on the part of healthcare providers 22
3.5.8 Emerging Technologies in the US Coronary Stents Market 23
3.5.8.1 Diamond like Carbon Coating (DLC) 23
3.5.8.2 Advanced Drug eluting coatings 23
3.5.8.3 Bioabsorbable Stents 23
3.5.8.4 Platinum Enriched Stainless Steel (PERSE) 25
3.5.8.5 Antibody coated or gene therapy stents 25
3.6 Future Outlook and Implications: US Coronary Stents Market 25
4 Mergers & Acquisitions 26
4.1 Mergers & Acquisitions in 2009 26
4.1.1 Boston Scientific Acquires Labcoat 26
4.2 Mergers & Acquisitions in 2007 26
4.2.1 Medtronic Acquires Setagon 26
4.3 Mergers & Acquisitions in 2006 26
4.3.1 Abbott Laboratories Acquires Vascular Business of Guidant From Boston Scientific 26
5 Coronary Stent Pipeline Products 27
5.1 Key Coronary Stents pipeline products 27
6 Appendix 41
6.1 Research Methodology 42
6.2 Coverage 43
6.3 Secondary Research 43
6.4 Primary Research 44
6.5 Models 44
6.6 Forecasts 45
6.7 Expert Panels 45
6.8 GlobalData Consulting 45
6.9 Contact Us 45
6.10 Disclaimer 46